Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

被引:0
作者
Alexandra Jobert
Edouard-Jules Laforgue
Marie Grall-Bronnec
Morgane Rousselet
Morgane Péré
Pascale Jolliet
Fanny Feuillet
Caroline Victorri-Vigneau
机构
[1] Nantes and Tours University,Inserm UMR 1246, SPHERE, Methods in Patients
[2] Centre Hospitalier Universitaire de Nantes,centered outcomes and Health Research
[3] University Hospital,Direction de la Recherche
[4] Centre Hospitalier Universitaire de Nantes,Pharmacologie clinique
[5] University Hospital,Addictologie et Psychiatrie de liaison
[6] Centre Hospitalier Universitaire de Nantes,undefined
[7] University Hospital,undefined
[8] French Addictovigilance Network,undefined
来源
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词
Benzodiazepine; Chronic use; Older people; Withdrawal symptoms; Z-drug;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:171 / 177
页数:6
相关论文
共 70 条
[1]  
Cloos J-M(2015)Hypnotics and Triazolobenzodiazepines--best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry Psychother Psychosom 84 273-283
[2]  
Bocquet V(2004)Practical geriatrics: use of benzodiazepines among elderly patients Psychiatr Serv 55 233-235
[3]  
Rolland-Portal I(1990)Psychiatric epidemiology in Quebec: an overview Can J Psychiatr 35 414-418
[4]  
Koch P(1996)Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world L’Encephale 22 187-196
[5]  
Chouinard G(2002)Benzodiazepine use and risk of dementia: a nested case–control study J Clin Epidemiol 55 314-318
[6]  
Bogunovic OJ(2001)Benzodiazepine use and wine consumption in the French elderly Br J Clin Pharmacol 52 455-460
[7]  
Greenfield SF(1991)Benzodiazepines and the elderly. A review of potential problems J Subst Abus Treat 8 35-41
[8]  
Kovess V(2003)Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature Acta Clin Belg 58 27-36
[9]  
Valla J-P(2000)Addiction: part I. benzodiazepines-side effects, abuse risk and alternatives Am Fam Physician 61 2121-553
[10]  
Tousignant M(2016)Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment J Clin Psychopharmacol 36 550-876